AQSZF
Price:
$0.0039
Market Cap:
$663.17K
Aequus Pharmaceuticals Inc., a specialty pharmaceutical company, develops and commercializes drugs in Canada. It focuses on various therapeutic areas, including neurology, ophthalmology, and transplantation. The company markets Vistitan, an ophthalmology product to reduce elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Tacrolimus IR, an immunosuppressant for the treatment and prevention of acute rejection following organ transplantation; Evolve dry eye products for various symptoms involved with dry eye disease and blepharitis, including discomfort, stinging, burning, and dryness; and preservative free ophthalmic product. Its development stage produ...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2015-06-16
Stock Exchange
PNK
Ticker
AQSZF
According to Aequus Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.39. This represents a change of -63.64% compared to the average of -1.07 of the last 4 quarters.
The mean historical PE Ratio of Aequus Pharmaceuticals Inc. over the last ten years is -4.90. The current -0.39 PE Ratio has changed 695.15% with respect to the historical average. Over the past ten years (40 quarters), AQSZF's PE Ratio was at its highest in in the September 2024 quarter at -0.67. The PE Ratio was at its lowest in in the December 2020 quarter at -20.35.
Average
-4.90
Median
-4.22
Minimum
-10.70
Maximum
-1.12
Discovering the peaks and valleys of Aequus Pharmaceuticals Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 230.48%
Maximum Annual PE Ratio = -1.12
Minimum Annual Increase = -82.34%
Minimum Annual PE Ratio = -10.70
Year | PE Ratio | Change |
---|---|---|
2023 | -1.12 | -22.66% |
2022 | -1.45 | -82.34% |
2021 | -8.19 | -23.45% |
2020 | -10.70 | 230.48% |
2019 | -3.24 | -22.60% |
2018 | -4.18 | -33.58% |
2017 | -6.30 | 166.01% |
2016 | -2.37 | -44.38% |
2015 | -4.26 | -41.40% |
2014 | -7.26 | -20.78% |
The current PE Ratio of Aequus Pharmaceuticals Inc. (AQSZF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-3.58
5-year avg
-4.94
10-year avg
-4.90
Aequus Pharmaceuticals Inc.’s PE Ratio is less than Amexdrug Corporation (4.30), greater than Aion Therapeutic Inc. (-0.71), less than Aspen Pharmacare Holdings Limited (9.53), greater than Antisense Therapeutics Limited (-3.23), greater than Alterola Biotech, Inc. (-2.85), greater than The BC Bud Corporation (-5.76), greater than Crescita Therapeutics Inc. (-4.15), greater than AusCann Group Holdings Ltd (-2.17),
Company | PE Ratio | Market cap |
---|---|---|
4.30 | $338.82K | |
-0.71 | $1.98M | |
9.53 | $5.44B | |
-3.23 | $19.64M | |
-2.85 | $4.38M | |
-5.76 | $4.81M | |
-4.15 | $8.58M | |
-2.17 | $1.67M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aequus Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Aequus Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Aequus Pharmaceuticals Inc.'s PE Ratio?
How is the PE Ratio calculated for Aequus Pharmaceuticals Inc. (AQSZF)?
What is the highest PE Ratio for Aequus Pharmaceuticals Inc. (AQSZF)?
What is the 3-year average PE Ratio for Aequus Pharmaceuticals Inc. (AQSZF)?
What is the 5-year average PE Ratio for Aequus Pharmaceuticals Inc. (AQSZF)?
How does the current PE Ratio for Aequus Pharmaceuticals Inc. (AQSZF) compare to its historical average?